Recall of t:slim X2 Insulin Pumps Due to Potential Battery Issues
Tandem Diabetes Care is recalling approximately 80,938 t:slim X2 Insulin Pumps worldwide due to potential battery issues that could cause the pump to stop functioning.
Use caution until it’s fixed
Tandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction within the drive module can reduce available motor power and, under certain conditions, cause motor speed to fall below the occlusion detection threshold. As a result, the pump may incorrectly detect an occlusion condition and suspend insulin delivery. When an occlusion alarm occurs, insulin delivery remains suspended until the user acknowledges the alarm and resumes therapy. Repeated false-positive occlusion alarms, if not addressed promptly, may result in interruptions of insulin delivery that can increase the risk of elevated blood glucose levels. In severe cases, hyperglycemia may require medical intervention or hospitalization.
What happened, in plain English
Tandem Diabetes Care, Inc. has issued a Class I recall for the t:slim X2 Insulin Pump. The recall affects approximately 80,938 units distributed worldwide, including nationwide distribution in the United States and Canada. The issue involves potential battery problems that may cause the pump to stop working unexpectedly. Read more at govinfonow.com/recall/2255638-tandem-diabetes-care-inc-recalls-tandem-mobi-insulin-pump-models.
Source Summary by GovInfoNow · govinfonow.com/recall/2255638-tandem-diabetes-care-inc-recalls-tandem-mobi-insulin-pump-models · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #Z-0316-2027
Cite this page
“Recall of t:slim X2 Insulin Pumps Due to Potential Battery Issues.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2255638-tandem-diabetes-care-inc-recalls-tandem-mobi-insulin-pump-models. Based on FDA recall #Z-0316-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0316-2027%22&limit=1).
Why it’s dangerous
The batteries in the affected pumps may fail, causing the pump to stop delivering insulin. This could lead to hyperglycemia or diabetic ketoacidosis (DKA) if not addressed promptly.
Who’s affected
Patients using the t:slim X2 Insulin Pump who have received devices from the recalled lots.
How to tell if you have this one
Check your t:slim X2 Insulin Pump's lot number against the recalled lots listed below. If your device is part of the recall, you will receive instructions on how to return it and receive a replacement.
- Brand
Tandem- Category
Medical device
What to do — step by step
1
Check the lot number on your t:slim X2 Insulin Pump.
2
If your lot number is included in the recall list, stop using the pump immediately and contact Tandem Diabetes Care for instructions on returning the device and receiving a replacement.
3
Monitor your blood glucose levels closely and follow your healthcare provider's advice regarding insulin management during the transition to a new pump.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 50 states.
FDA distribution: “Worldwide - US Nationwide distribution including in the states of CA, FL, NC, OK, UT, WA, IL, PA, MN, VA, NY, IN, HI, OR, GA, MI, KS, CO, WI, SC, null, TX, NE, AZ, OH, NM, NV, MA, SD, IA, TN, ID, MD, RI, CT, NJ, ME, KY, MT, WV, VT, MS, AR,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 49 days after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the t:slim X2 Insulin Pump?
The t:slim X2 Insulin Pump is a wearable device used by people with diabetes to deliver insulin continuously.
Similar recalls
Other Tandem recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0316-2027 (September 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0316-2027 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.